+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Effect of flunixin meglumine and firocoxib on ex vivo cyclooxygenase activity in horses undergoing elective surgery



Effect of flunixin meglumine and firocoxib on ex vivo cyclooxygenase activity in horses undergoing elective surgery



American Journal of Veterinary Research 76(3): 208-215



To evaluate ex vivo cyclooxygenase (COX) inhibition and compare in vitro and ex vivo COX-1 inhibition by flunixin meglumine and firocoxib in horses. 4 healthy horses for in vitro experiments and 12 healthy horses (6 males and 6 females; 5 Thoroughbreds, 5 Warmbloods, and 2 ponies) undergoing elective surgery for ex vivo experiments. 12 horses received flunixin meglumine (1.1 mg/kg, IV, q 12 h) or firocoxib (0.09 mg/kg, IV, q 24 h). Blood samples were collected before (baseline) and 2 and 24 hours after NSAID administration. Prostanoids (thromboxane B2, prostaglandin E2, and prostaglandin E metabolites) served as indicators of COX activity, and serum drug concentrations were measured by use of high-performance liquid chromatography. An in vitro coagulation-induced thromboxane B2 assay was used to calculate drug concentration-COX-1 inhibition curves. Effect of time and treatment on COX activity was determined. Agreement between in vitro and ex vivo measurement of COX activity was assessed with Bland-Altman analysis. At 2 and 24 hours after NSAID administration, COX-1 activity was reduced, compared with baseline activity, for the flunixin meglumine group only and relative COX-1 activity was significantly greater for the firocoxib group, compared with that for the flunixin meglumine group. There was no significant change in COX-2 activity after surgery for either group. Bland-Altman analysis revealed poor agreement between in vitro and ex vivo measurement of COX-1 activity. Compared with flunixin meglumine, firocoxib had COX-1-sparing effects ex vivo in equine patients that underwent elective surgery.

(PDF emailed within 0-6 h: $19.90)

Accession: 057704136

Download citation: RISBibTeXText

PMID: 25710756

DOI: 10.2460/ajvr.76.3.208


Related references

Distribution of flunixin meglumine and firocoxib into aqueous humor of horses. Journal of Veterinary Internal Medicine 25(5): 1127-1133, 2012

Effects of Firocoxib, Flunixin Meglumine, and Phenylbutazone on Platelet Function and Thromboxane Synthesis in Healthy Horses. Veterinary Surgery 45(8): 1087-1094, 2016

Multicentre, blinded, randomised clinical trial comparing the use of flunixin meglumine with firocoxib in horses with small intestinal strangulating obstruction. Equine Veterinary Journal 2018: -, 2018

Use of the prostaglandin synthesis inhibitor, flunixin meglumine, to prevent shock in horses undergoing surgery for colic. Pferdeheilkunde 5(5): 275-284, 1989

The effect of flunixin meglumine, firocoxib and meloxicam on the uterine mobility of equine embryos. Theriogenology 123: 132-138, 2018

Effect of firocoxib or flunixin meglumine on recovery of ischemic-injured equine jejunum. American Journal of Veterinary Research 70(8): 992-1000, 2009

Effect of body weight on the pharmacokinetics of flunixin meglumine in miniature horses and quarter horses. Journal of Veterinary Pharmacology and Therapeutics 37(1): 35-42, 2014

Disposition of flunixin after intramuscular administration of flunixin meglumine to horses. Journal of Veterinary Pharmacology & Therapeutics 20(4): 330-332, 1997

Effect of flunixin meglumine on prostanoids in horses with mechanical ileus. Pratique Veterinaire Equine 28(4): 261-267, 1996

Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses. American Journal of Veterinary Research 58(11): 1291-1299, 1997

Effect of flunixin meglumine on plasma prostanoid concentrations in horses with colic in the perioperative period. Dtw. Deutsche Tierarztliche Wochenschrift 104(9): 365-368, 1997

Flunixin meglumine (Banamine): use in horses. Annali della Facolta di medicina veterinaria Universita di Parmaub 1982) 1(1): 91-98, 1982

Disposition and excretion of flunixin meglumine in horses. American Journal of Veterinary Research 49(11): 1894-1898, 1988

The effects of flunixin, meglumine and phenylbutazone on cyclooxygenase in inflamed tissue and platelets. British Journal of Pharmacology 120(PROC SUPPL ): 236P, 1997

Effect of flunixin meglumine on selected physiologic and performance parameters of athletically conditioned thoroughbred horses subjected to an incremental exercise stress test. Veterinary Therapeutics 3(1): 37-48, 2002